INTRODUCTION
============

The kinetochore is a complex multiprotein machine that directs chromosome segregation at mitosis ([@B61]; [@B48]; [@B68]; [@B13]; [@B33]). Kinetochore structure changes dramatically across the cell cycle from a ball of condensed chromatin containing the specialized histone H3 subtype CENP-A during interphase ([@B9]; [@B46]; [@B23]; [@B63]) to a trilaminar plate during mitosis ([@B58]). To fully understand kinetochore maturation, we need not only a complete parts list, but also a dynamic map of protein neighborhoods during this remarkable structural transformation.

Following the initial discoveries of centromere proteins using autoantibodies ([@B47]; [@B30]; [@B23]), characterization of the kinetochore proteome continued with the isolation of kinetochore subcomplexes using antibodies to CENP-A ([@B1]) and tandem affinity tags ([@B14]; [@B29]; [@B35]). However, such affinity-purification methods are not well suited to identify either transient low-affinity protein--protein interactions or those that occur in the context of insoluble subcellular structures such as mitotic chromosomes or kinetochores. Traditional affinity-purification methods all begin with solubilization of the target protein, a procedure that can disrupt important protein--protein interactions. This has been overcome, at least in part, by the development of methods such as EMARS (enzyme-mediated activation of radical sources; [@B71]) and SPPLAT (selective proteomic proximity labeling assay using tyramide; [@B54]), allowing in situ proximity-based labeling of proteins in cells.

In EMARS horseradish peroxidase (HRP) is coupled to an antibody, protein ligand, or a fusion protein, for localization purposes at the plasma membrane. The labeling is performed using aryl azide-biotin or aryl azide-fluorescein. When oxidized by HRP in the presence of H~2~O~2~, these substrates bind to proteins proximal to the localized HRP. SPPLAT labeling differs only in that biotin-tyramide is used as the substrate.

Neighborhood mapping of intracellular proteins began with in vivo BioID ([@B59]; [@B39]; [@B43]) in which a promiscuous mutant form of the bacterial biotin ligase BirA (BirA^R118G^, henceforth referred to as BirA\*) was used to transfer biotin to nearby proteins ([@B16]). This method was first used for mapping the neighborhood of lamin A, leading to the identification of a novel nuclear envelope protein ([@B59]). Subsequently, the method has been applied to many proteins of interest including insoluble, membrane-associated proteins in many eukaryotic cells ([@B2]; [@B12]; [@B27]; [@B15]; [@B41]). It has also been applied to whole plant systems ([@B72]).

APEX (proximity labeling with ascorbate peroxidase) has recently been developed as an alternative to in vivo BioID ([@B73]). Initially APEX did not attempt to provide maps of interactors: the ascorbate peroxidase was expressed in a compartment-specific manner. To initiate labeling, cells are incubated with H~2~O~2~ and biotin-phenol (a tyramide derivative) so the reaction can occur in the same manner as described for EMARS and SPPLAT. More recently, APEX has been expressed as a fusion protein enabling it to be used in a protein-specific manner to map the neighborhoods of microproteins ([@B73]) and β-2 adrenergic receptor ([@B45]).

All of these methods harbor both strengths and weaknesses. The original in vivo BioID method required cells to be incubated with 50 µM biotin for 18--24 h, during which time targets are continuously biotinylated. This approach is therefore not compatible with the proteomic study of dynamic processes. In contrast, HRP-based methods offer superior temporal resolution. Cells are typically incubated with 500 µM of substrate for 30 min, before the addition of H~2~O~2~, for as little as 1 min. A concern with this approach, however, is that substrate labeling occurs wherever the fusion protein happens to be (i.e., both assembled at its ultimate destination, but also at all stages along the way to that destination following its translation), reducing its spatial resolution. Furthermore, HRP has been reported to be more prone to unfolding and loss of activity than wild-type BirA ([@B54]).

The caveats with published labeling methods and low copy numbers of kinetochore components relative to potential contaminants, led us to consider alternative approaches to study kinetochore maturation during mitosis. We noted that both wild-type ([@B26]) and mutant versions of BirA ([@B16]) had previously been shown to be functional in vitro, albeit in restricted experimental conditions. We therefore explored the possibility that BioID labeling might be achievable in lysed cells. Remarkably, this appears to work extremely well. Our new in vitro method allows essentially instantaneous labeling of protein neighborhoods from the point of view of the cell cycle, because the cells are no longer living and are "frozen" at the point of lysis. To validate the method, we use in vitro *BioID* (ivBioID) to report initial descriptions of the protein neighborhoods of kinetochore protein CENP-A using a CENP-A:BirA\* fusion protein under the control of an inducible promoter. Here we compare changes in the CENP-A neighborhood during interphase and mitosis. We report the surprising finding that several CENP-A chaperones appear to be stably associated with both interphase and mitotic chromatin, an unexpected finding also recently reported by others ([@B69]).

RESULTS AND DISCUSSION
======================

To identify proteins of the CENP-A neighborhood, we tagged CENP with BirA^R118G^ (yielding BirA\*-CENP-A) and generated a stable HeLa cell line in which BirA\*-CENP-A was induced following doxycycline addition. Following a 24 h treatment with doxycycline plus 50 μM added biotin ([Figure 1](#F1){ref-type="fig"}A), BirA\*-CENP-A was detected at centromeres in both interphase and mitotic cells ([Figure 1](#F1){ref-type="fig"}B, anti-myc). Labeling with fluorescent streptavidin was consistent with centromeric staining and confirmed that the BirA\* was functional ([Figure 1](#F1){ref-type="fig"}B, streptavidin 488). In addition to the anticipated centromeric biotinylation, a diffuse signal was detected throughout the nucleus, nucleoli, and mitochondria ([Figure 1](#F1){ref-type="fig"}B).

![Testing in vivo BioID using CENP-A. (A) Flowchart describing how HeLa tet-on cells, stable for the conditional expression of myc-BirA\*CENP-A (BirA\*--CENP-A), were cultured in media supplemented with doxycycline and 50 µm biotin for 24 h before processing for either microscopy or mass spectrometry. (B) Cells fixed and processed for immunofluorescence. The panels show representative examples of cells in interphase and mitosis probed with streptavidin 488 (green), anti-myc (red), and stained with DAPI (blue). (C) Immunoblot analysis of affinity-purified material from control (parental HeLa cell line) or BirA\*--CENP-A expressing cells. Blots were probed with streptavidin 800 IR LI-COR labels. (D--F) HeLa cells were seeded into CLEM dishes and cell culture media was supplemented with doxycycline and 50 μm biotin for 24 h. Cells were fixed, permeabilized, and probed with Alexa Fluor 488 dye--labeled colloidal gold, conjugated to streptavidin (Molecular Probes), and imaged using LM to identify mitotic cells of interest. Cells were embedded in resin, sectioned, and imaged by transmission electron microscopy (TEM). (D) Low-magnification images showing the metaphase plate of mitotic cell chosen for CLEM. Images are DAPI (blue), regions of biotinylation (green), and the same cell reidentified by TEM. (E) Two progressive zooms of the boxed region shown in D, shown as LM merge (left), TEM (middle), and LM-TEM merge (overlay, right). Bottom panels (Zoom 2) show 9× magnifications of the white box in D. Top panels (Zoom 1) are a 3× magnification intermediate of part of the white box in D. Contrast-rich areas are visible corresponding to centromeres. The scale bar shows 100 nm (top) and 20 nm (bottom). (F) Pixel density analysis. Line scans (five to six per kinetochore---indicated in panel Fi, top) were taken through kinetochores, originating in the centromere and terminating in the cytoplasm, among kinetochore microtubules. The bottom left panel is an enlargement of the white box in Fi, showing a representative line scan passing through the kinetochore and terminating in the cytoplasm. The bottom right panel shows gold particles only, spotted onto a carbon film for comparison. Pixel densities were compiled and represented as a histogram (Fii). Predicted subcellular positions are noted beneath the histogram. *N*~cell~ = 2. *N*~kinetochore~ = 12. Bar = 20 nm. (G) Summary of the MS data returned for in vivo BirA\*--CENP-A. Numbers in brackets represent the ranked position of CENP-A within the MS data, based on protein score.](mbc-30-1314-g001){#F1}

To determine the distance traveled by activated biotin before derivatizing a target protein we measured the dispersion of biotin from BirA\*-CENP-A using correlative light and electron microscopy (CLEM). CENP-A is an excellent substrate for this because it is organized as a linear structure in the inner kinetochore plate. To determine the range of distances traveled by activated biotin following its release from BirA\*-CENP-A, we performed the in vivo BioID protocol, then stained cells with Alexa Fluor 488 streptavidin conjugated to 5 nm colloidal gold. We then measured the distribution of gold around kinetochores ([Figure 1](#F1){ref-type="fig"}, D--F). Overview images confirm that a mitotic cell of interest was identified and followed from LM (light microscopy) imaging through to EM (electron microscopy; [Figure 1](#F1){ref-type="fig"}D). Higher-magnification images confirmed that individual chromosomes and their centromeres could also be followed ([Figure 1](#F1){ref-type="fig"}E, Zoom 1). Further examination of the images confirmed that centromeres visualized by LM correlated accurately with electron dense gold particles decorating linear "plates" in electron micrographs ([Figure 1](#F1){ref-type="fig"}E, Zoom 2). The distribution of colloidal gold particles was measured using line scans, taken perpendicular to the long axis of the kinetochore plates ([Figure 1](#F1){ref-type="fig"}Fi, red bars). High-magnification images confirmed that "in situ" gold particles ([Figure 1](#F1){ref-type="fig"}Fi, bottom left panel) resembled free gold particles spotted onto Formvar-coated grids ([Figure 1](#F1){ref-type="fig"}Fi, bottom right panel). The line-scan density profile revealed a remarkably narrow distribution of gold particles, with an overall span of ∼20 nm ([Figure 1](#F1){ref-type="fig"}Fii). This correlates remarkably well with the thickness of kinetochore plates measured by thin-section electron microscopy ([@B56]) and with previous estimates of the distances traveled by activated biotin (10--20 nm; [@B59]; 10 nm; [@B38]).

Because the half width of the gold distribution was only ∼10 nm, this experiment suggests that the activated biotin travels only a very limited distance before derivatization of a target protein. We would expect a sharp cutoff to this distribution outside the chromosome, because any labeled cytosolic proteins would presumably diffuse away from the site of labeling. In contrast, chromatin is relatively immobile, so we would have expected the labeling in subjacent chromatin to reflect the distance traveled by activated biotin. The fact that relatively little gold was found in the chromatin flanking the inner surface of the kinetochore strongly supports the assumption that BioID does indeed measure protein neighborhoods at the molecular level.

To characterize the specificity of the in vivo BioID method, cells expressing BirA\*-CENP-A were subjected to the original BioID protocol (*Materials and Meth*ods) and then lysed and biotinylated proteins enriched by binding to streptavidin beads ([Figure 1](#F1){ref-type="fig"}C). The affinity-purified material was then analyzed by mass spectrometry. In control experiments, cells not expressing BirA\*-CENP-A were grown in the presence of 50 µm biotin, and affinity purifications performed in parallel. This in vivo analysis returned more than 500 hits, with CENP-A itself ranked at position 298, based on peptide score ([Figure 1](#F1){ref-type="fig"}G and Supplemental Table 1). After subtracting proteins identified in the control pull downs, this experiment yielded a list of more than 300 proteins ([Figure 1](#F1){ref-type="fig"}G and Supplemental Table 2) with CENP-A now ranked at position 109.

Although there were likely genuine proteins from the CENP-A neighborhood on this list, no other centromere proteins were detected. Furthermore, given that CENP-A itself was ranked so far down the list, we concluded that attempting to identify other members of the CENP-A neighborhood by this approach would be unlikely to succeed. It was also evident that this approach (which requires labeling for 18--24 h in the presence of high biotin concentrations) could never allow us to discriminate between cell cycle--­dependent interacting partners of CENP-A.

To address these problems of labeling specificity and temporal resolution, the method needed to be improved in two key areas: 1) BirA\*-specific labeling of target proteins over much shorter reaction times and 2) better discrimination between specific and nonspecific biotinylation targets.

Indeed, the intracellular pool of free biotin is an issue with the published in vivo BioID protocol, as growing cells for less than 18--24 h in medium supplemented with 50 µM biotin yielded low levels of BirA\* labeling of target proteins ([@B59]). At physiological levels (e.g., the concentration of biotin in fetal bovine serum \[FBS\]), the uptake of biotin into cells is relatively slow ([@B20]; [@B11]), and although increasing the biotin concentration can increase its uptake ([@B11]; [@B57]), this improves only until transporter saturation is reached ([@B52]; [@B19]).

We speculated that one way to solve this problem and achieve rapid labeling of substrates with low backgrounds would be to conduct the biotinylation reaction in vitro, using permeabilized cells. To test whether such an in vitro system would be feasible, we designed a two-step protocol combining mild permeabilization of cells with incubation in a biotinylation reaction buffer ([Figure 2](#F2){ref-type="fig"}A). Strikingly, we found that BirA\* was active under these conditions ([Figure 2](#F2){ref-type="fig"}, C--E), yielding biotinylation signals comparable to those obtained with a 24 h incubation in vivo ([Figure 2](#F2){ref-type="fig"}B).

![Rapid in vitro biotinylation (ivBioID) of CENP-A. (A) Flowchart of ivBioID method. (B) Immunofluorescence of in vivo prepared BirA\*--CENP-A cells. In panels B and E, 24 h^+^ represents an in vivo BioID sample extracted with 0.1% Triton X-100 before fixation. Panels *t* = 0 represent a sample with no biotin incubation. (C) Summary of results of cells prepared using the protocol described in A, under a variety of detergent extraction conditions. (D) Immuno­fluorescence of ivBioID--CENP-A prepared cells. Cells were permeabilized with 0.1% Triton X-100 extraction for 2 min. Several biotinylation buffer incubation time points were tested. Cells were fixed and processed for IF as standard and labeled with streptavidin 488 (green) or anti-myc (red). In panels D and E, 15 min\* represents cells incubated with biotin buffer lacking ATP. Bar = 5 μm; Zoom bar = 1 μm. (E) Bar graph showing quantification of centromeric immunofluorescence from samples prepared as for B and D. Bars show the mean fluorescence of streptavidin 488 normalized to myc fluorescence. *N*~cell~ = 20. *N*~centromere~ = 200.](mbc-30-1314-g002){#F2}

The in vitro biotinylation worked efficiently and reproducibly but was sensitive to the conditions used to permeabilize the cells. Extraction of cells with SDS at concentrations of \>0.01% appeared to abolish the reaction, and at 0.01% SDS, only occasional weak labeling was observed ([Figure 2](#F2){ref-type="fig"}C). Of the conditions tested, brief extraction of cells with Triton X-100 at concentrations up to 0.1% appeared to be the most suitable for preserving BirA\* functionality in the in vitro reaction ([Figure 2](#F2){ref-type="fig"}C), and this concentration was used for all subsequent experiments.

We measured the efficiency of in vitro biotinylation ([Figure 2](#F2){ref-type="fig"}D) by quantifying the fluorescence levels of streptavidin-Alexa 488 at centromeres following differing incubation periods with biotinylation buffer ([Figure 2](#F2){ref-type="fig"}E). In control experiments, using the established in vivo BioID protocol, BirA\*-CENP-A produced robust levels of biotinylation at centromeres ([Figure 2](#F2){ref-type="fig"}, B and E). Our in vitro protocol, which we refer to as in vitro *BioID* (*ivBioID*), was less efficient, but yielded clear centromeric biotinylation after as little as 2 min of incubation with biotinylation buffer. Only minor differences were observed between biotinylation buffer incubations of 2, 5, and 10 min; however, longer incubations did result in greater levels of biotinylation ([Figure 2](#F2){ref-type="fig"}, D and E). In control experiments, removing either biotin or ATP from the reaction buffer resulted in almost undetectable levels of biotinylation ([Figure 2](#F2){ref-type="fig"}, D and E).

Clear visual evidence for the increased specificity of the in vitro biotinylation came from examining the results of in vitro biotinylation on mitotic chromosome spreads. Cells expressing BirA\*-CENP-A were arrested in mitosis with nocodazole, hypotonically swollen, and centrifuged onto glass slides. The ivBioID reaction was then performed, with labeling for 20 min. This procedure gave highly specific biotin labeling of the centromeres of mitotic chromosomes ([Figure 3](#F3){ref-type="fig"}, A--C). In contrast, when cells were processed for the conventional in vivo BioID protocol and similar chromosome spreads were prepared, the biotin labeling was seen not only at centromeres, but also all along the chromosome arms ([Figure 3](#F3){ref-type="fig"}, D--F). It is therefore clear that the ivBioID protocol can yield a more selective labeling of the neighborhood of the target protein.

![Chromosome spreads from both in vivo and in vitro prepared samples. Qualitative samples were prepared for comparison of in vivo and in vitro BioID samples. Experimental conditions include cells not expressing BirA\*--CENP-A and not treated with biotin (A and D); cells expressing BirA\*--CENP-A but not treated with biotin (B and E); cells expressing BirA\*--CENP-A and treated with biotin (C and F). All samples were fixed and probed with DAPI, anti-myc (red), and streptavidin 488 (green). Zooms are of the white boxed region in "MERGE." Bar = 5 and 1 μm.](mbc-30-1314-g003){#F3}

Biotinylation with sub--cell cycle resolution
---------------------------------------------

Having obtained evidence that ivBioID allows rapid biotinylation of substrates by BirA\*, we next investigated whether this approach would also provide a more selective method for mapping protein neighborhoods. Our ultimate goal was to ask whether ivBioID could detect differences in the CENP-A neighborhood across the cell cycle. Indeed, immunofluorescence experiments confirmed that mitotic cells can also be labeled efficiently by the ivBioID protocol (Supplemental Figure 1).

For mass spectrometry analysis, we conducted an ivBioID reaction on larger amounts of interphase and mitotic cells, affinity purified the biotinylated material using streptavidin beads, and analyzed the bound proteins by mass spectrometry ([Figure 4](#F4){ref-type="fig"}A). Coomassie staining of the streptavidin pull downs revealed that samples prepared after ivBioID of mitotic cells contained less material than those obtained from interphase cells ([Figure 4](#F4){ref-type="fig"}B). Streptavidin labeling also suggested that levels of recovered protein were lower from mitotic than from interphase cells.

![Production of samples for ivBioID analysis of CENP-A. (A) Comparison of original in vivo BioID (top) and in vitro BioID (bottom) methodologies showing addition of the permeabilization step and post lysis biotinylation. (B) Coomassie blue stain gel of samples submitted for MS showing controls and hit samples. (C) Western blot of samples submitted for MS showing controls and hit samples. Biotinylation can be seen in the bottom panel, and anti-myc--BirA\*--CENP-A can be seen in the top panel.](mbc-30-1314-g004){#F4}

Mass spectrometry analysis returned a total of 659 proteins from three repeats following ivBioID of interphase cells and 506 proteins from three repeats from ivBioID of mitotic cells. In control experiments, 484 and 369 proteins were recovered from interphase or mitotic cells not expressing the BirA\* fusion protein (-doxycycline) and 455 and 355 proteins were recovered from interphase or mitotic reactions performed in the absence of biotin. To identify the most specific ivBioID--CENP-A interactors we firstly background-subtracted proteins identified in control experiments; secondly, only considered hits present in at least two of the three repeats; and lastly, removed all proteins whose abundance score in the mass spectrometer fell below a minimum confidence threshold. The final list returned 20 and 9 proteins for the interphase and mitotic samples, respectively ([Figure 5](#F5){ref-type="fig"}A). Importantly, both lists contained CENP-A, CENP-B, and CENP-C.

![Analysis of the CENP-A neighborhood in interphase and mitosis using ivBioID. (A) Venn diagram showing the final filtered hit lists for interphase (green) and mitotic (yellow) samples and how they overlap with one another. Interphase hits labeled with \* were also observed in the mitotic hit list but were under the confidence level. The overlap in red shows those proteins seen in both interphase and mitotic lists. (B) Proteins observed in the interphase ivBioID final hit list (green) show overlap with known CENP-A interacting proteins. The bulk of the proteins detected by ivBioID correspond to proteins previously found in the ICEN complex (yellow overlap; [@B1]; [@B49]; [@B36]) and the CENP-A prenucleosomal complex (blue overlap; [@B29]). The other proteins not detected in our analysis but found in the original descriptions of the ICEN complex (orange) and CENP-A prenucleosomal complex (pale yellow) are also shown. Hits labeled with + were previously found in pull downs using either CENP-A or themselves as the target.](mbc-30-1314-g005){#F5}

Validation of the CENP-A neighborhood in interphase and mitosis
---------------------------------------------------------------

Combining the CENP-A data from both interphase and mitotic cells over the three experiments yielded a comprehensive list of proteins proximal to CENP-A as determined by this method ([Figure 5](#F5){ref-type="fig"}A). Importantly, most of these proteins had been previously shown in other studies to be associated with CENP-C in chromatin or in its preassembly complexes.

From the list of CENP-A interphase interactors, two groups of proteins became apparent ([Figure 5](#F5){ref-type="fig"}B). The first is found in the interphase centromere complex (ICEN)---the first published set of CENP-A--associated proteins, which were identified by the Yoda lab. The ICEN complex was a cohort of 40 proteins purified from HeLa cells following micrococcal nuclease digestion of chromatin and immunoprecipitation with a monoclonal antibody to CENP-A ([@B1]; [@B49]; [@B36]). Remarkably, nine of the 20 interphase ivBioID hits are found in the list of ICEN proteins, including CENP-A itself. The other eight proteins are CENP-B, CENP-C, PHIP, SUPT16H, DDB1, SRRT, HSPA8, and FIB.

The appearance of CENP-C was expected, because this protein has been shown to bind directly to CENP-A ([@B22]; [@B28]; [@B10]; [@B31]). Although CENP-C is not strictly dependent on CENP-A for localization to kinetochores in *Drosophila* ([@B24]) or in chicken DT40 cells ([@B60]), it does appear to require CENP-A for kinetochore localization in human cells and in *Caenorhabditis elegans* ([@B50]; [@B44]). Similarly, the interaction between CENP-B and CENP-A nucleosomes at the centromere is very well characterized, although the role of CENP-B remains under intensive study ([@B25]; [@B34]). The role of the other ICEN proteins at centromeres remains to be determined.

A second group of six proteins observed in the list of interphase ivBioID hits is found in the CENP-A prenucleosomal complex. These are HJURP, NPM1, DDX17, EIF4A1, XRCC5, and DDX3X. This complex is involved in CENP-A deposition. Indeed, HJURP is the chaperone that inserts CENP-A into chromatin. The CENP-A prenucleosomal complex presumably exists in both interphase and mitosis so that cells are ready for CENP-A deposition at centromeres specifically in a window during mitotic exit when CDK1 activity drops ([@B37]; [@B66]). It was surprising that this complex was detected by ivBioID, because the protocol involves a detergent permeabilization step that would be expected to wash away soluble proteins and protein complexes. Our analysis thus suggests that the CENP-A prenucleosomal complex must be relatively stably engaged either at centromeres or at other sites on chromatin both in interphase and during mitosis. This unexpected observation has recently been confirmed by others ([@B69]).

Of the four remaining proteins found by interphase ivBioID with CENP-A, three were previously reported in immunoprecipitation studies for interactions with CENP-A. NOL8, PARP1, and PRKDC were either found by using CENP-A or themselves as the bait protein ([@B62]; [@B65]; [@B21]; [@B32]). Remarkably, the only interphase "hit" protein not previously recovered in a complex with CENP-A is Aurora B kinase. However, Aurora B and Aurora A can both phosphorylate CENP-A on serine 7 ([@B70]; [@B40]; [@B4]). This phosphorylation has been reported to have an unexpected role in regulating cytokinesis ([@B70]) and also to be involved in localization of the CPC to centromeres ([@B40]). Surprisingly, in our study, biotinylated Aurora B was observed in the absence of its three auxiliary CPC subunits INCENP, Survivin, and Borealin.

The list of mitotic proteins in the CENP-A neighborhood was much shorter. Aside from CENP-B and CENP-C we recovered two members of the prenucleosomal complex (DDX5 and HNRNPC). Again, it was unexpected and interesting that two members of the CENP-A prenucleosomal complex would be associated with mitotic CENP-A. Among the others, PBH2 was reported to be involved in kinetochore assembly and protecting sister chromatid cohesion ([@B67]; [@B42]), but has not been reported to be linked with CENP-A. The other three proteins, RPL8 (a ribosomal protein), RBM39 (a splicing factor), and GTPBP4 (a nucleolar GTP-binding protein), do not have obvious links to kinetochores or CENP-A and determination of their link to CENP-A requires further investigation.

Gene ontology analysis of hits
------------------------------

To better understand the CENP-A neighborhood during interphase and mitosis, gene ontology analysis was carried out on the two hit lists. The biological functions of the proteins in both of these lists ([Figure 6](#F6){ref-type="fig"}) show a large crossover between the functions of the proteins found in both interphase and mitosis, the largest of these groups being kinetochore assembly. This was expected, particularly when considering that a greater percentage of the mitotic hits are seen to be involved in this process. Also prominent were other chromatin-related categories, including nucleosome organization, ATP-dependent chromatin remodeling, sister chromatid cohesion, and chromosome organization.

![GO enrichment analysis of interphase and mitotic ivBioID hit lists. GO analysis using the hit lists obtained from the MS reveals enrichment for a subset of biological processes and cellular components. Both sets of samples were run through the g-Profiler toolkit ([@B55]) and the significant terms (*P* \< 0.01) for each sample were recorded (Supplemental Table 3). We calculate log~2~ enrichment for each GO term using the fraction of these terms per sample against the ratio of these terms in the database used by g-Profiler. (A) Biological processes in which the proteins found in the hit lists are enriched. (B) Cellular process in which the proteins found in the hit lists are enriched.](mbc-30-1314-g006){#F6}

Looking more generally at the cellular components in which the proteins fall ([Figure 6](#F6){ref-type="fig"}B), all our proteins fell into only four categories: nuclear pericentric heterochromatin, granular components, centromeric protein, and nuclear lumen. All but the granular components are nuclear/chromatin specific. The association with the granular component of the nucleolus is less obvious. Indeed, some of these proteins, which are extremely abundant in cells, could be contaminants.

We can conclude from this analysis that the ivBioID method generates lists of enriched proteins that are relevant for CENP-A--­related activities. Thus, the method appears to have high specificity and to be capable of detecting relatively nonabundant components of insoluble cellular structures.

Perspective
-----------

The ivBioID method reveals information about the CENP-A neighborhood that differs from interaction maps reported by classical methods such as two hybrid screens and tandem affinity pull-down screens. Thus, ivBioID provides an additional, orthogonal method for the exploration of protein relationships. The method revealed a majority of proteins that were previously known to interact directly with CENP-A, including CENP-C, CENP-B, and HJURP; it also offered insights into the changes in the CENP-A environment at interphase and mitosis. Interestingly, despite the stability of CENP-A nucleosomes in vivo ([@B3]), its environment is characterized by dynamic chromatin, as shown by the presence of proteins specific for chromatin remodeling as well as CENP-A nucleosome assembly.

Because the ivBioID method works with cells that have been harvested and permeabilized and are no longer physiologically active, it offers what is effectively "instantaneous" time resolution of cellular processes. Thus, if cultures can be synchronized or sorted, this method should offer a useful approach to determining differences in protein neighborhoods in cells grown under normal conditions without stresses imposed by exposure to extended and high concentrations of biotin or transient shock with H~2~O~2~. Furthermore, because the bulk of soluble proteins are removed by the detergent extraction, the method exhibits a remarkably low background, provided that the goal is to look at relatively stable structural interactions.

Since these experiments were performed, a new method for in vivo biotin labeling of protein neighborhoods known as "TurboID" has been published ([@B8]). The authors used directed evolution to produce a highly mutated BirA that can biotinylate target proteins in vivo in HEK 293T cells in as little as 10 min and also in living *Drosophila melanogaster* and *C. elegans*. TurboID clearly addresses a number of the difficulties with previous in vivo BioID methods, and provides a powerful complement to the in vitro method described here. TurboID provides much longer lists of potential neighbors (which can be a strength or a weakness) and should be able to detect weak or transient interactions. In contrast, ivBioID provides lower background, much shorter hit lists, can analyze changes over even finer time intervals (e.g., a minute or even less in highly time-sensitive processes like mitosis), and will presumably detect primarily stable interactions (which may be easier to validate than weak or transient interactions). Furthermore, it should be useful in any cell type or organism, independent of the biotin transport or endogenous pools. Together, classic BioID ([@B59]) and these new methods are opening up powerful new approaches to analyzing protein proximities in cells.

MATERIALS AND METHODS
=====================

Cell culture
------------

HeLa cells were maintained in DMEM containing 10% FBS and 100U/ml penicillin/streptomycin at 37°C and 5% CO~2~.

For preparation of stable cell lines, CENP-A was amplified by PCR from HeLa cDNA and cloned into pcDNA3.1-mycBioID vector (Addgene) using *Not*1 and *Afl*2 restriction sites. Myc-BirA(R118G)--CENP-A was amplified by PCR from pcDNA3.1-mycBioID--CENP-A vector and cloned into a tet-on 3G inducible expression vector (Clontech). Tet-On 3G vectors were cotransfected, with a linear resistance gene, into HeLa cells expressing the tetracycline-regulated transactivator (Clontech), using GeneJuice (Novagen). Stable cell lines were enriched using antibiotic selection for 7--14 d. Surviving clones were expanded and screened for the stable, inducible expression of Myc-BirA(R118G)--CENP-A (otherwise known as BirA\*--CENP-A) by immunofluorescence microscopy. Expression of the fusion protein was observed in \>90% of cells in the selected culture.

Indirect immunofluorescence microscopy
--------------------------------------

Cells were fixed in 4% paraformaldehyde (PFA) and processed as previously described ([@B7]). The primary antibodies or fluorescent labels used were as follows: anti--α-tubulin antibody (B512; Sigma); anti-myc Alexa Fluor 555 conjugate (Millipore); streptavidin Alexa Fluor 488 conjugate (Life Technologies); and anti--CENP-C. Three-dimensional data sets were acquired using a cooled CCD camera (CH350; Photometrics) on a wide-field microscope (DeltaVision Spectris; Applied Precision) with a NA 1.4 Plan Apochromat lens. The data sets were deconvolved with softWoRx (Applied Precision). Three-dimensional data sets were converted to Quick Projections in softWoRx, exported as TIFF files, and imported into Adobe Photoshop or Adobe Illustrator for final presentation.

CLEM
----

The CLEM processing method was adapted from previously established protocols ([@B6], 2013, 2014). Briefly, HeLa cells conditionally expressing BirA\*--CENP-A were seeded onto glass-bottomed gridded dishes (MatTek Corporation) in medium supplemented with biotin (50 µM) and doxycycline (1 µg/ml). Following a 24 h expression period, cells were fixed using a mixture of glutaraldehyde and paraformaldehyde for 1 h. Next, cells were permeabilized, blocked in 3% bovine serum albumin, and probed with Alexa Fluor 488 dye--labeled colloidal gold, conjugated to streptavidin (Molecular Probes), for 1 h. Samples were washed (in phosphate-buffered saline \[PBS\] containing Hoechst) and cells of interest identified using a wide-field epifluorescence microscope (DeltaVision RT; Applied Precision). Cells with centromere labeling were located and their position mapped using transmitted light to visualize reference coordinates. Cells were then postfixed for 20 min in 1.5% PFA, before osmication (0.5% osmium tetroxide in PBS), dehydrated (using a graded series of ethanol), and embedded in resin. Once cured, ultrasmall resin blocks (50 µm^2^) were fine trimmed and serial sections (85 nm thickness) taken at areas corresponding to previously chosen coordinate positions. Cells were visualized with a Phillips CM120 BioTwin transmission electron microscope (FEI) and micrographs acquired using a Gatan Orius CCD camera (Gatan).

The appropriate Z position correlative light/EM images of a cell were concatenated using ImageJ and then analyzed and overlaid using Photoshop Elements 6 (Adobe).

Centromeric gold labeling and pixel density analysis
----------------------------------------------------

Electron micrographs containing mitotic chromosomes were selected for analysis of gold particles at the centromere. The pixel density of a 1 µm region of interest (ROI) was measured using the raw data from the "plot profile" function of ImageJ. For unbiased consistency, the 1 µm ROI always started within the chromosome body and finished in the cytoplasm, with the halfway point lying at the region most dense with gold label. Approximately 150 individual pixel density measurements were taken within each 1 µm region. The data were plotted as a line-scan profile, with each data point representing the mean of 6 × 1 µm regions of interest per centromere.

In vivo BioID method
--------------------

This was based on the method described by [@B59]. Cells were seeded into 4 × 10 cm dishes and incubated for 24 h in complete media supplemented with 1 μg/ml doxycycline and 50 μM biotin. Cells were trypsinized, centrifuged, and resuspended in 1 ml lysis buffer at 25°C (50 mM Tris, pH 7.4, 500 mM NaCl, 0.4% SDS, 5 mM EDTA, 1 mM dithiothreitol \[DTT\], and 1× complete protease inhibitor \[Roche\]), and sonicated. Triton X-100 was added to 2% final concentration. After further sonication, an equal volume of 4°C 50 mM Tris (pH 7.4) was added before additional sonication (subsequent steps at 4°C) and centrifugation at 16,000 × *g*. Supernatants were incubated with 100 μl Dynabeads (MyOne steptavadin C1; Invitrogen) for 1 h at RT. Beads were collected and washed twice for 8 min at 25°C (all subsequent steps at 25°C) in 1 ml wash buffer 1 (2% SDS in dH~2~O). This was repeated once with wash buffer 2 (0.1% deoxycholate, 1% Triton X-100, 500 mM NaCl, 1 mM EDTA, and 50 mM HEPES, pH 7.5), once with wash buffer 3 (250 mM LiCl, 0.5% NP-40, 0.5% deoxycholate, 1 mM EDTA, and 10 mM Tris, pH 8.1), and twice with wash buffer 4 (50 mM Tris, pH 7.4, and 50 mM NaCl). Ten percent of the sample was reserved for Western blot analysis. Bound proteins were eluted from the magnetic beads with 50 μl of Laemmli SDS sample buffer saturated with biotin at 98°C. Eluent (90%) was submitted for mass spectrometry analysis.

In vitro BioID method
---------------------

Cells were seeded into 10 cm dishes for asynchronous cells and 15 cm dishes for mitotic cells and incubated for 24 h in complete medium supplemented with 1 μg/ml doxycycline. For mitotic samples cells were treated with nocodozole (100 ng/ml) for 13 h. Mitotic cells were enriched via mitotic shake off. Asynchronous cells were collected via trypsinization. Cells were centrifuged and resuspended in 0.1% Triton X-100 in PBS for 1.5 min at 37°C. Samples were centrifuged and washed once in warmed PBS before incubation in biotinylation buffer (40 mM Tris:HCl, pH 8.0, 5 mM MgCl~2~, 3 mM ATP, 100 µM KCl, 50 µM biotin) for 15 min at 37°C. Cells were centrifuged and washed once in warmed PBS, before resuspension in 100 μl solubilization buffer at 25°C (50 mM triethanolamine:HCl, pH 7.4, 100 mM NaCl, 2 mM K-EDTA, pH 7.4, 0.4% SDS, 2 mM β-mercaptoethanol, 0.1 mM phenylmethylsulfonyl fluoride, 0.1% trasylol, 1 µg/ml chymostatin, leupeptin, antipain, pepstatin \[CLAP\]), and sonicated at 4°C. Samples were then centrifuged at 16,000 × *g*. Supernatants were transferred to clean tubes before addition of 400 µl RIPA buffer (50 mM Tris:HCl, pH 8.0, 150 mM NaCl, 1% Na deoxycholate, 0.1% SDS, 1× cOmplete ULTRA protease inhibitor; Roche) and subsequent incubation with 100 μl Dynabeads (MyOne steptavadin C1; Invitrogen) for 18 h at 4°C. Beads were collected and washed twice for 5 min at 25°C rotating (all subsequent steps at 25°C) in 1 ml PBS containing 500 mM NaCl. Subsequently two washes were performed in 1 ml PBS containing 250 mM NaCl, followed by two washes in 1 ml PBS and a final wash in 1 ml mass spectrometry grade H~2~O. Bound proteins were eluted from the magnetic beads with 50 μl of Laemmli SDS sample buffer saturated with biotin at 95°C. Ten percent of the sample was reserved for Western blot analysis. Ninety percent of the eluent was submitted for mass spectrometry analysis.

Immunoblotting analysis
-----------------------

For immunoblotting, 10% of the total eluent, purified for mass spectrometry, was loaded onto polyacrylamide gels. SDS--PAGE and immunoblotting were performed following standard procedures. The antibodies or fluorescent labels used were as follows: anti-myc 9E10 (Abcam); IRDye 800CW streptavidin (LI-COR); anti-mouse IRDye 680CW (LI-COR).

Mass spectrometry analysis
--------------------------

Protein samples were run on gels (NuPAGE Novex 4--12% Bis-Tris gel; Life Technologies, UK), in NuPAGE buffer (MES) and visualized using Imperial protein stain (Life Technologies, UK). The stained gel bands were excised and destained with 50 mM ammonium bicarbonate (Sigma Aldrich, UK) and 100% (vol/vol) acetonitrile (Sigma Aldrich, UK), and proteins were digested with trypsin, as previously described ([@B64]). Briefly, proteins were reduced in 10 mM DTT (Sigma Aldrich, UK) for 30 min at 37°C and alkylated in 55 mM iodoacetamide (Sigma Aldrich, UK) for 20 min at ambient temperature in the dark. They were then digested overnight at 37°C with 13 ng μl^−1^ trypsin (Pierce, UK).

Following digestion, samples were diluted with equal volumes of 0.1% trifluoroacetic acid (TFA) and spun onto StageTips as described by [@B53]. Peptides were eluted in 40 μl of 80% acetonitrile in 0.1% TFA and concentrated down to 1 μl by vacuum centrifugation (Concentrator 5301; Eppendorf, UK). Samples were then prepared for liquid chromatography--mass spectrometry (LC-MS)/MS analysis by diluting them to 6 μl with 0.1% TFA. LC-MS analyses were performed on a Q Exactive mass spectrometer (Thermo Fisher Scientific, UK) coupled online, to an Ultimate 3000 RSLCnano System (Dionex; Thermo Fisher Scientific, UK). Peptides were separated on a 50 cm EASY-Spray column (Thermo Fisher Scientific, UK) assembled in an EASY-Spray source (Thermo Fisher Scientific, UK) and operated at 50°C. Mobile phase A consisted of 0.1% formic acid in water, whereas mobile phase B consisted of 80% acetonitrile and 0.1% formic acid. Peptides were loaded onto the column at a constant flow rate of 0.3 μl min^−1^ and eluted at a flow rate of 0.2 μl min^−1^ according to the following gradient: 2--40% mobile phase B in 120 min, then to 95% in 11 min. Fourier transform mass spectrometry spectra were recorded at 70,000 resolution (scan range 350--1400 m/z) and the 10 most intense peaks with charge ≥2 of the MS scan were selected with an isolation window of 2.0 Thomson for MS2 (filling 1.0E6 ions for MS scan, 5.0E4 ions for MS2, maximum fill time 60 ms, dynamic exclusion for 50 s). Fragmentation was performed by employing HCD ([@B51]) with normalized collision energy of 27.

The MaxQuant software platform ([@B17]) version 1.5.2.8 was used to process raw files and searches were conducted against *Homo sapiens* complete/reference proteome set of Uniprot database (released in March 2017), using the Andromeda search engine ([@B18]). For the first search, peptide tolerance was set to 20 ppm, whereas for the main search peptide tolerance was set to 4.5 ppm. Isotope mass tolerance was 2 ppm and the maximum charge was 7. A maximum of two missed cleavages was allowed. Carbamidomethylation of cysteine was set as a fixed modification. Oxidation of methionine and acetylation of the N-terminal were set as variable modifications. Peptide and protein identifications were filtered to 1% false discovery rate.

Filtering and analysis of hits
------------------------------

The following approach was used to reduce the background and obtain hits lists. First, the three repeats were combined, yielding one list for each experimental condition. Next those lists were filtered, keeping only proteins for which at least two independent peptides had been identified. Subsequently, proteins found in either of the control lists---1) cells not expressing BirA\*--CENP-A and 2) cells that had not been exposed to biotin---were subtracted from the corresponding master list of interphase or mitotic hits. The data were further filtered by removing proteins that were not observed in at least two of the repeats. Finally, a confidence level based on peptide score (a comparison of the observed spectrum for each peptide with the theoretically calculated spectrum for that peptide; [@B17]) was applied to the interphase and mitotic hit lists. Proteins with a score below 1 were removed, thereby yielding the final hit lists for both conditions.

Bioinformatics and gene ontology analysis
-----------------------------------------

Final hit lists from both conditions were run through the g-Profiler toolkit ([@B55]) and the significant terms (*P* \< 0.01) for each sample were recorded in the output. This was then used to calculate log~2~ enrichment for each gene ontology (GO) term using the fraction of these terms per sample against the ratio of these terms in the database used by g-Profiler.
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APEX

:   ascorbate peroxidase

BioID

:   Biotin ID

BSA

:   bovine serum albumin

CDK1

:   cyclin dependent kinase 1

CENP-A

:   centromere protein A

CLAP

:   chymostatin, leupeptin, antipain, pepstatin

CLEM

:   correlative light electron microscopy

CPC

:   chromosome passenger complex

DAPI

:   4′,6-diamidino-2-phenylindole

DTT

:   dithiothreitol

EM

:   electron microscopy

EMARS

:   enzyme-mediated activation of radical sources

FBS

:   fetal bovine serum

HRP

:   horseradish peroxidase

ICEN

:   inner centromere complex

ivBioID

:   in vitro Biotin ID

LC--MS

:   liquid chromatography--mass spectrometry

LM

:   light microscopy

PBS

:   phosphate-buffered saline

PFA

:   paraformaldehyde

PMSF

:   phenylmethylsulfonyl fluoride

ROI

:   region of interest

SPPLAT

:   selective proteomic proximity labeling assay using tyramide

TFA

:   trifluoroacetic acid

[^1]: ^†^Joint first authors.
